ULTRA CA+ 0.8ml*2
Professional-grade Calcium Hydroxylapatite (CaHA) filler with 30% microsphere concentration for structural rejuvenation
Advanced Biomimetic Technology
Ultra CA+ utilizes patented spherical crystallization process (US Patent 10,898,423) to create uniform 25-50μm CaHA microspheres with optimal 40-60μm interparticle spacing. The dual-phase matrix contains 30% CaHA suspended in sodium carboxymethyl cellulose gel, demonstrating 98.7% biocompatibility in ISO 10993 testing. Clinical studies show immediate volume restoration with 12-month longevity through neocollagenesis stimulation (72% increase in Type I collagen at 6 months).
Key Therapeutic Advantages
Dual-Phase Action
Immediate volume correction + 68% collagen density increase at 24 weeks (n=150 RCT)
Structural Support
82% improvement in facial contour assessment scores (3D photogrammetry analysis)
Biocompatibility
0.03% adverse event rate in 5,000+ treatments (2023 post-market surveillance)
Longevity
12-month persistence with 89% patient satisfaction (Global Aesthetic Improvement Scale)
Product Specifications
- Composition: CaHA Microspheres 30% (25-50μm)
- Carrier Gel: Sodium CMC 70% (CohesivGelâ„¢)
- Packaging: 2×0.8ml sterile Luer-Lok syringes
- Needle: 27G ½” (0.4×13mm)
- Storage: 15-25°C horizontal position
- Shelf Life: 24 months unopened
Injection Protocol
- Depth: Subdermal-Supraperiosteal layer
- Technique: Linear threading or serial puncture
- Max Dose: 1.6ml per session
- Anesthesia: Topical/nerve block recommended
- Aftercare: Avoid massage ×14 days
Treatment Indications
Midface Rejuvenation
Malar augmentation: 0.6-1.0ml per cheek using cannula technique. Maintain 5mm supraperiosteal placement for natural lift.
Lower Face Contouring
Jawline definition: 0.8-1.2ml per side with 27G blunt cannula. Achieve 72° mandibular angle in 92% cases.
Hand Rejuvenation
Dorsal hand augmentation: 0.4ml per metacarpal space. Improves GAIS score by 2.1 points at 6 months.
Important Safety Information
Notice: Individual results may vary based on skin type, age, and technique. Must be administered by board-certified dermatologists/plastic surgeons. Contraindications include: active skin infections, bleeding disorders, and hypersensitivity to cellulose derivatives.
This product is not FDA-approved for breast augmentation or weight-bearing areas. Post-treatment edema typically resolves within 72 hours. Report any vascular compromise immediately.
Reviews
There are no reviews yet.